Therefore, these results suggest that HSP90AA1 may have similar promoting effects as NAT10 in metastasis, cell cycle arrest, apoptosis resistance, and lenvatinib resistance of ERS HCC. This evidence concerns the gene NAT10 and hepatocellular carcinoma.